About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Vineet Laboratories Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
543298
ISIN Demat
INE505Y01010
Book Value
27.18
NSE Code
VINEETLAB
Dividend Yield %
0.00
Market Cap
302.11
P/E
0.00
EPS
-8.40
Face Value
10
BSE
NSE
17-Apr-2025
BSE
NSE
NSE F & O
17-Apr-2025
BSE
NSE
NSE F & O
Last Price
32.77
Net Change
-1.04
% Change
-3.08%
Prev.Close
33.81
Open
34.00
High
34.00
Low
32.60
Volume
1162
Last Price
32.74
Net Change
-0.45
% Change
-1.36%
Prev.Close
33.19
Open
33.69
High
33.87
Low
32.16
Volume
54694
Value
38432
Best Buy
0.00
Best Sell
0.00
Best Quantity
0
Sell Quantity
0
Today's Range
34.00
52-Week High
78.48
52-Week Low
30.00
Value
1809231.07
Best Buy
0.00
Best Sell
32.74
Best Quantity
0
Sell Quantity
883
Today's Range
33.87
52-Week High
78.45
52-Week Low
30.31
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
0
Price
0.00
Best Bid
Best Offer
Quantity
0
Price
0.00
Quantity
883
Price
32.74
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Book Closure
19-Sep-24
27-Sep-24
Dividend
10 %
20-Sep-22
Company News
16-04-2025
Vineet Laboratories infor...
13-02-2025
Vineet Laboratories infor...
04-02-2025
Vineet Laboratories infor...
05-09-2024
Vineet Laboratories infor...
04-09-2024
Vineet Laboratories submi...
02-11-2023
Vineet Laboratories infor...
13-10-2023
Vineet Laboratories infor...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.
